脾肿大评估

Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Feb;92(2):209-17.全文  摘要

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.全文  摘要

Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.全文  摘要

Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.全文  摘要

1. Lichtin AE, Cook JR. Diseases of the spleen. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:697-705.

2. McKenzie CV, Colonne CK, Yeo JH, et al. Splenomegaly: pathophysiological bases and therapeutic options. Int J Biochem Cell Biol. 2017 Dec 2;94:40-3. 摘要

3. Sjoberg BP, Menias CO, Lubner MG, et al. Splenomegaly: a combined clinical and radiologic approach to the differential diagnosis. Gastroenterol Clin North Am. 2018 Sep;47(3):643-66. 摘要

4. Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005 May;21(3):323-30. 摘要

5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma [internet publication].全文

6. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].全文

7. ​​​National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hodgkin lymphoma [internet publication]全文

8. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long term follow-up of no initial therapy. J Clin Oncol. 2004 Apr 15;22(8):1454-9.全文  摘要

9. Koc O, Wilson WH. Non-Hodgkin's lymphoma. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:579-95.

10. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004 Nov 15;104(10):3009-20.全文  摘要

11. Gavriatopoulou M, Musto P, Caers J, et al. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia. 2018 Sep;32(9):1883-98. 摘要

12. Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017 Feb;92(2):209-17.全文  摘要

13. Frater JL. T-cell prolymphocytic leukemia: review of an entity and its differential diagnostic considerations. Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-8. 摘要

14. Licata MJ, Janakiram M, Tan S, et al. Diagnostic challenges of adult T-cell leukemia/lymphoma in North America - a clinical, histological, and immunophenotypic correlation with a workflow proposal. Leuk Lymphoma. 2018 May;59(5):1188-94. 摘要

15. Kutok JL, Fletcher CD. Splenic vascular tumors. Semin Diagn Pathol. 2003 May;20(2):128-39. 摘要

16. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90.全文  摘要

17. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hairy cell leukemia [internet publication].全文

18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: myeloproliferative neoplasms [internet publication].全文

19. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: acute lymphoblastic leukemia [internet publication].全文

20. Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008 Aug 7;359(6):575-83.全文  摘要

21. Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006 Mar 15;106(6):1306-15. 摘要

22. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology. 2004 Jun;18(7):837-44. 摘要

23. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000 Apr 27;342(17):1255-65. 摘要

24. Tefferi A, Rumi E, Finazzi G, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013 Sep;27(9):1874-81.全文  摘要

25. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2361-71.全文  摘要

26. Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020 Apr 16;135(16):1332-43.全文  摘要

27. Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2015;2015:177-82.全文  摘要

28. Jordan MB, Allen CE, Greenberg J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019 Nov;66(11):e27929.全文  摘要

29. La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun 6;133(23):2465-77.全文  摘要

30. Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.全文  摘要

31. Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20. 摘要

32. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007 Feb;48(2):124-31. 摘要

33. Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005 Aug;17(4):519-24. 摘要

34. Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002 Oct;25(6):491-500. 摘要

35. World Health Organization. ​WHO Guidelines for malaria. Mar 2023 [internet publication].全文

36. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA. 2007 May 23;297(20):2264-77. 摘要

37. Leoni S, Buonfrate D, Angheben A, et al. The hyper-reactive malarial splenomegaly: a systematic review of the literature. Malar J. 2015 Apr 29;14:185.全文  摘要

38. Kan FK, Tan CC, Von Bahr Greenwood T, et al. Dengue infection complicated by hemophagocytic lymphohistiocytosis: experiences from 180 patients with severe dengue. Clin Infect Dis. 2020 May 23;70(11):2247-55.全文  摘要

39. Giang HTN, Banno K, Minh LHN, et al. Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol. 2018 Nov;28(6):e2005. 摘要

40. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008 Nov 15;112(10):3939-48.全文  摘要

41. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008 Nov 15;112(10):3927-38.全文  摘要

42. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006 May 11;354(19):2034-45. 摘要

43. Shmueli H, Flint N, Pollick C, et al. Spleen size and appearance by transesophageal echocardiography in patients with suspected infective endocarditis. JACC Cardiovasc Imaging. 2020 Apr;13(4):1082-3.全文  摘要

44. Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003 Mar 15;361(9361):943-51. 摘要

45. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013 Jul 30;108(9):1400-15.全文  摘要

46. American Society for Clinical Pathology. Choosing wisely: testing for amylase. Sep 2016 [internet publication].全文

47. Cessford T, Meneilly GS, Arishenkoff S, et al. Comparing physical examination with sonographic versions of the same examination techniques for splenomegaly. J Ultrasound Med. 2018 Jul;37(7):1621-9. 摘要

48. Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303-29.全文  摘要

49. Gary SE, Ryan E, Steward AM, et al. Recent advances in the diagnosis and management of Gaucher disease. Expert Rev Endocrinol Metab. 2018 Mar;13(2):107-18.全文  摘要

50. Batur A, Alagoz S, Durmaz F, et al. Measurement of spleen stiffness by shear-wave elastography for prediction of splenomegaly etiology. Ultrasound Q. 2019 Jun;35(2):153-6. 摘要

51. İmamoğlu H, Zararsız G, Özdemir M, et al. The orthogonal measurements approach in estimating spleen size on CT images. Diagn Interv Radiol. 2020 Jan;26(1):5-10.全文  摘要

52. Indiran V, Vinod Singh N, Ramachandra Prasad T, et al. Does coronal oblique length of spleen on CT reflect splenic index? Abdom Radiol (NY). 2017 May;42(5):1444-8. 摘要

53. Kucybała I, Ciuk S, Tęczar J. Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen? Abdom Radiol (NY). 2018 Sep;43(9):2455-61.全文  摘要

54. Gunes SO, Akturk Y. Determination of splenomegaly by coronal oblique length on CT. Jpn J Radiol. 2018 Feb;36(2):142-50. 摘要

55. Huo Y, Liu J, Xu Z, et al. Robust multicontrast MRI spleen segmentation for splenomegaly using multi-atlas segmentation. IEEE Trans Biomed Eng. 2018 Feb;65(2):336-43.全文  摘要

56. Huo Y, Xu Z, Bao S, et al. Splenomegaly segmentation on multi-modal MRI using deep convolutional networks. IEEE Trans Med Imaging. 2019 May;38(5):1185-96.全文  摘要

57. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019 Jan;94(1):133-43.全文  摘要

58. Cetin G, Ozkan T, Turgut S, et al. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. Mol Biol Rep. 2014 Oct;41(10):6737-42. 摘要

59. Karaköse S, Oruç N, Zengin M, et al. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis. Turk J Gastroenterol. 2015 Jan;26(1):42-8.全文  摘要

60. Thurmes PJ, Steensma DP. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis. Eur J Haematol. 2006 Jul;77(1):57-60. 摘要

61. Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Nov 6;69(1):394-419.全文  摘要

62. Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019 Aug;68(8):1356-78.全文  摘要

63. Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.全文  摘要

64. Mehta A, Kuter DJ, Salek SS, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019 May;49(5):578-91.全文  摘要

65. Deshwal R. Clinical and laboratory profile of hospitalized malarial patients: an Agra-based study. J Assoc Physicians India. 2016 Aug;64(8):44-7.全文  摘要

66. Guo C, Zhou Z, Wen Z, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317.全文  摘要

67. World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Oct 2009 [internet publication].全文

68. Ferreira BDC, Correia D. Ultrasound assessment of hepatobiliary and splenic changes in patients with dengue and warning signs during the acute and recovery phases. J Ultrasound Med. 2019 Aug;38(8):2015-24. 摘要